IGC Pharma, Inc.IGCNYSE
Loading
Net Margin Over TimeExpanding
Percentile Rank29
Studio
Year-over-Year Change

Net income as a percentage of revenue

Latest
-560.27%
↑ 32% vs avg
Percentile
P29
Within normal range
Streak
3 yr
Consecutive growthExpanding
Average
-826.03%
Historical baseline
PeriodValueYoY Change
2025-560.27%+42.0%
2024-966.54%+23.5%
2023-1263.01%+66.6%
2022-3782.37%-285.5%
2021-981.18%-446.2%
2020-179.64%-124.3%
2019-80.08%+1.7%
2018-81.44%+74.7%
2017-321.69%-629.4%
2016-44.10%-